Rationale of Technical Requirements for NRG-BR001: The First NCI-Sponsored Trial of SBRT for the Treatment of Multiple Metastases

INTRODUCTION: In 2014, the NRG Oncology Group initiated the first NCI-sponsored, phase I clinical trial of SBRT for the treatment of multiple metastases in multiple organ sites (XXXX; NCTXXX). The primary endpoint is to test the safety of SBRT for the treatment of multiple lesions (2–4) in several a...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Pract Radiat Oncol
Prif Awduron: Al-Hallaq, Hania A, Chmura, Steven, Salama, Joseph K, Winter, Kathryn A, Robinson, Clifford G, Pisansky, Thomas M, Borges, Virginia, Lowenstein, Jessica L, McNulty, Susan, Galvin, James M, Followill, David S, Timmerman, Robert D, White, Julia R, Xiao, Ying, Matuszak, Martha M
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: 2016
Pynciau:
Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC5099083/
https://ncbi.nlm.nih.gov/pubmed/27345129
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.prro.2016.05.004
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg